Earnings summaries and quarterly performance for NU SKIN ENTERPRISES.
Executive leadership at NU SKIN ENTERPRISES.
Ryan Napierski
Detailed
President and Chief Executive Officer
CEO
CC
Chayce Clark
Detailed
Executive Vice President and General Counsel
JT
James Thomas
Detailed
Executive Vice President and Chief Financial Officer
JK
Justin Keisel
Detailed
Executive Vice President and President of Global Sales
SH
Steven Hatchett
Detailed
Executive Vice President and Chief Product Officer
Board of directors at NU SKIN ENTERPRISES.
Research analysts who have asked questions during NU SKIN ENTERPRISES earnings calls.
David Storms
Stonegate Capital Partners
3 questions for NUS
Also covers: ACOG, AMTX, ARLP +19 more
AH
Ashley Helgans
Jefferies
2 questions for NUS
Also covers: BBWI, COTY, ELF +9 more
Chasen Bender
Citigroup
2 questions for NUS
Also covers: HLF
SX
Song Xue
D.A. Davidson & Co.
1 question for NUS
Also covers: LCUT, USNA
Sydney Wagner
Jefferies
1 question for NUS
Also covers: BBWI, COTY, ELF +5 more
Recent press releases and 8-K filings for NUS.
Nu Skin Details Prysm iO Rollout and India Market Entry Plans for 2026
NUS
Product Launch
New Projects/Investments
Revenue Acceleration/Inflection
- Nu Skin is launching Prysm iO, an IoT-connected device that leverages Biophotonic Scanner technology and AI to provide personalized nutritional health scores and product solutions, with a significant rollout planned throughout 2026.
- The company is strategically entering the Indian market in mid to late 2026, applying successful strategies from its Latin American expansion and partnering with local entities like Infosys for a digital-first approach.
- Nu Skin has diversified its business by rebalancing its six regional segments plus Rhyz to be of approximately equal size, reducing over-reliance on any single market and enhancing overall business stability.
- CEO Ryan Napierski stated that Nu Skin is significantly undervalued by the market due to its direct sales channel, despite its innovation, technology, and efficient customer acquisition costs, positioning itself as an "intelligent beauty and wellness platform".
Jan 12, 2026, 6:30 PM
Nu Skin Enterprises Announces Q3 2025 Results and Strategic Initiatives
NUS
Earnings
Guidance Update
Product Launch
- Nu Skin Enterprises reported Q3 2025 revenue of $364 million and EPS of 34 cents, which was within and at the higher end of their guidance range, respectively.
- The company provided Q4 2025 revenue guidance between $365 million and $400 million and EPS between 25 cents and 35 cents. For the full year 2025, revenue guidance was narrowed to $1.48 billion to $1.51 billion, while adjusted EPS guidance was maintained at the high end of $1.25 to $1.35.
- Nu Skin is preparing for the introduction of Prism IO, an intelligent wellness platform, with 10,000 units anticipated to be placed in Q4 2025 and a full-scale launch in 2026.
- The company is also expanding its emerging market strategy into India, with a pre-market opening beginning in Q4 2025 and a full-scale opening anticipated in the back half of 2026.
Nov 6, 2025, 10:00 PM
Nu Skin Announces Q3 2025 Results and Q4/FY 2025 Outlook
NUS
Earnings
Guidance Update
Demand Weakening
- Nu Skin reported Q3 2025 revenue of $364.2 million, representing a 15.3% year-over-year decrease (or 11.5% excluding Mavely).
- Earnings Per Share (EPS) for Q3 2025 was $0.34, an increase from $0.17 in Q3 2024.
- The company experienced declines in key operational metrics year-over-year, with Customers down 10%, Paid Affiliates down 13%, and Sales Leaders down 19% in Q3 2025.
- Gross Margin for Q3 2025 was 70.5%, and Operating Margin was 5.9%.
- For Q4 2025, Nu Skin forecasts revenue between $365 million and $400 million and EPS between $0.25 and $0.35. The full-year 2025 revenue guidance is $1.48 billion to $1.51 billion, with adjusted EPS projected at $1.25 to $1.35 (excluding Mavely gain and other charges).
Nov 6, 2025, 10:00 PM
Nu Skin Enterprises Reports Q3 2025 Earnings and Updates 2025 Guidance
NUS
Earnings
Guidance Update
Product Launch
- Nu Skin Enterprises reported Q3 2025 revenue of $364.2 million, a 15.3% decrease compared to the prior-year quarter, and diluted earnings per share (EPS) of $0.34, up from $0.17 in Q3 2024.
- For Q4 2025, the company projects revenue between $365 million and $400 million and EPS between $0.25 and $0.35. Full-year 2025 revenue is expected to be $1.48 billion to $1.51 billion, with EPS of $3.15 to $3.25.
- The company is preparing for the limited introduction of its Prysm iO intelligent wellness platform in late Q4 and pre-market opening activities in India this month, with a formal launch planned for the second half of 2026.
Nov 6, 2025, 9:06 PM
Nu Skin Enterprises Reports Q4 2024 Results, Provides 2025 Guidance, and Announces Mavely Sale
NUS
Earnings
Guidance Update
M&A
- Nu Skin Enterprises reported Q4 2024 revenue of $445.6 million and adjusted earnings per share of $0.38, exceeding its guidance range. The company's full-year 2024 revenue was $1.73 billion.
- The company sold its Rhyz portfolio business, Mavely, for $250 million, generating a five-times return on investment and adding approximately $200 million in cash to the balance sheet. $115 million of these proceeds were used to reduce debt in Q1 2025.
- For full-year 2025, Nu Skin projects revenue between $1.48 billion and $1.62 billion and adjusted earnings per share between $0.90 and $1.30. Q1 2025 revenue is anticipated to be between $345 million and $365 million, with adjusted EPS between $0.10 and $0.20 (excluding the Mavely transaction).
- Strategic priorities for 2025 include strengthening the core Nu Skin business, accelerating innovation of its iO intelligent beauty and wellness platform, and improving operational performance and efficiency, with a plan to optimize the global product portfolio by more than 50% by the end of 2025.
- The company continues to navigate persistent headwinds in China and South Korea, while observing encouraging growth in the Americas, Latin America, Southeast Asia-Pacific, and Japan.
Feb 13, 2025, 10:00 PM
Nu Skin Enterprises Exceeds Q4 2024 Guidance, Announces Mavely Sale, and Provides 2025 Outlook
NUS
Earnings
Guidance Update
M&A
- Nu Skin Enterprises reported Q4 2024 revenue of $445.6 million and adjusted earnings per share of $0.38, both exceeding guidance. The company reduced debt by $110 million in 2024 and generated $70 million in free cash flow.
- In January 2025, the company announced the sale of Mavely for $250 million, which generated a five-times return on investment and added approximately $200 million in cash to the balance sheet. $115 million of these proceeds were used to reduce outstanding debt in Q1 2025.
- For 2025, Nu Skin projects revenue between $1.48 billion and $1.62 billion and adjusted earnings per share between $0.90 and $1.30, reflecting 7%-55% growth.
- The company's 2025 strategic priorities include strengthening its core business, accelerating innovation in its iO intelligent beauty and wellness platform, and improving operational performance and efficiency. Persistent headwinds are expected in China and South Korea, while Latin America and parts of Southeast Asia show encouraging growth.
Feb 13, 2025, 10:00 PM
Quarterly earnings call transcripts for NU SKIN ENTERPRISES.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more